Skip to content
Medical Health Aged Care, National News Current Affairs

ADA welcomes call for sugar tax as sickly sweet

The Australian Dental Association 2 mins read

7 May 2024

ADA welcomes call for sugar tax as sickly sweet


Australian Dental Association (ADA) President Dr Scott Davis welcomes the Grattan Institute’s report, Sickly sweet, which reiterates the ADA’s call for the introduction of a levy on sugary drinks.

“Australia must implement a tax on sugary drinks to not only curb the country’s obesity crisis but importantly to slow down the rate of tooth decay,” said Dr Davis, a NSW prosthodontist.

“As we know from numerous research studies and as made clear by this Grattan report, sugary drink taxes have led to improvements in oral health in several countries around the globe which have already instituted a levy on sugary drinks.”

The ADA has been calling on the Australian Government for many years to introduce a levy on sugary drinks that would then provide funding for targeted oral health programs, as outlined in the ADA’s Dental Health Plan. The nation’s oral health has been declining – the ADA’s Adult Oral Health Tracker[1] demonstrates that almost one-third of Australian adults have tooth decay with an almost 7% increase between 2004-06 and 2017-18.

Also just this year, the ADA highlighted in the ADA’s Children and Young People Oral Health Tracker[2], the number of Australian children captured in data for potentially preventable hospitalisations due to dental disease has also continued to rise. As of 2021-22, 10.8 per 1,000 children aged 5-9 years were hospitalised due to potentially preventable dental disease. This is a  problem which was directly addressed by the introduction of a levy in the UK, which led to a 12 per cent reduction in hospital admissions for removal of decayed teeth in children.

“As long as our government drags its feet, Australia will remain behind the 100 plus countries around the world which have taken the step to combat sugar consumption via sugar-sweetened beverages,” said Dr Davis.

Ends.

 

To interview Dr Davis, contact ADA Media Advisor Jenny Barlass on 0497 748 331.



[1] Australian Dental Association 2024. Australia’s Adult Oral Health Tracker 2024, Mitchell Institute, Victoria University, Melbourne. ada.org.au/oralhealthtracker.

[2] Australian Dental Association 2024. Australia’s Children and Young People Oral Health Tracker 2024, Mitchell Institute, Victoria University, Melbourne. ada.org.au/oralhealthtracker.


Contact details:

Jenny Barlass ADA Federal Media Advisor 0497 748 331

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.